Background National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015.
Introduction
Quantifying how much personal health care can improve population health and ultimately health-system performance is a crucial undertaking, particularly following the inclusion of universal health coverage (UHC) in the Sustainable Development Goals (SDGs).
1 Mortality from causes considered amenable to personal health care serve as an important proxy of health-care access and quality (panel), 4, [6] [7] [8] and thus can be used to benchmark dimensions of health-system performance and to identify untapped potential for advancing personal health-care access and quality. [9] [10] [11] [12] Much debate exists concerning the relative contributions of personal health care, populationlevel health initiatives, and social determinants to population health. [13] [14] [15] [16] Studies show that access to highquality health care substantially improves many health outcomes, including infectious diseases (eg, tuberculosis and measles); [17] [18] [19] maternal and neonatal disorders; 20, 21 
Research in context
Evidence before this study In the last several decades, various studies have used measures of amenable mortality, or deaths that could be avoided in the presence of high-quality personal health care, to garner signals about health-system delivery, effectiveness, and performance. Rutstein and colleagues developed an initial list of conditions from which death was "unnecessary and untimely" during the late 1970s, while Charlton and colleagues were the first to apply this concept to population-level analyses in England and Wales. Although variations of amenable cause lists exist today, the most widely used cause list of 33 conditions was developed and further honed by Nolte and McKee during the early-to-mid 2000s. Such analyses of health-care access and quality, as approximated by amenable mortality, have been limited to Europe, Organisation for Economic Co-operation and Development (OECD) countries, and country-specific assessments, including the USA, Australia, and New Zealand. These studies acknowledge several methodological challenges that may impede the policy utility and applications of their results. Heterogeneity in cause of death certification and misclassification, even for countries with complete vital registration systems, can hinder comparability of results over time and place. Further, researchers commonly acknowledge that variations in measured amenable mortality rates may be more reflective of differences in underlying risk factor exposure rather than true differences in personal health-care access and quality.
Added value of this study
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides an appropriate analytic framework through which these main challenges in approximating personal health-care access and quality can be addressed. First, the extensive cause of death data processing and standardisation that occur within GBD allow for the systematic identification and redress of cause of death certification errors or misclassification. These adjustments are conducted across all geographies and over time, accounting for known misclassification patterns and applying well established redistribution algorithms for causes designated to so-called garbage codes, or causes of death that could not or should not be classified as underlying causes of death. Second, we draw on GBD's comparative risk assessment analyses to risk-standardise national cause-specific mortality rates to global levels of risk exposure; this step helps to remove variations in death rates due to risk exposure rather than differences in personal health-care access and quality. Third, we construct the Healthcare Access and Quality (HAQ) Index based on risk-standardised cause-specific death rates to facilitate comparisons over time and by geography. Finally, we produced a HAQ Index frontier to enable a better understanding of the maximum observed levels of the HAQ Index across the development spectrum, and what untapped potential for improving personal health-care access and quality may exist given a country or territory's current resources.
Previously, several technical challenges have emerged concerning the quantification of mortality from conditions amenable to personal health care and its use for understanding overall health-care access and quality. First, discrepancies in cause of death certification practices and misclassification over time and across geographies affect comparisons of amenable mortality. 4, 36 Second, observed geographic and temporal variations in deaths from selected amenable causes (eg, stroke and heart disease) might be attributed partly differences in risk factor exposure (eg, diet, high BMI, and physical activity) rather than actual differences in access to quality personal health care. Public health programmes and policies might modify these risks in well-functioning health systems, but risk variation can still confound the measurement of personal health-care access and quality. Third, much of this work has occurred in higher-income settings, with few studies applying the concept of amenable mortality as a mechanism for assessing access and quality to personal health care in lower-resource settings. Other critiques involve weak correlations between observed trends and variations in amenable mortality and indicators of healthcare provision and spending, although this result could
Panel: Context and definitions
With the present analysis, we use the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to approximate average levels of personal health-care access and quality for 195 countries and territories from 1990 to 2015. Here we define key concepts frequently used in the literature focused on assessing health-care quality and how they relate to GBD terminology:
Avertable burden refers to disease burden that could be avoided in the presence of high-quality personal health care in addition to disease burden that could be prevented through effective public health (ie, non-personal) interventions.
Amenable burden entails disease burden that could be avoided in the presence of high-quality personal health care. 2, 3 To be considered a cause amenable to personal health care, effective interventions must exist for the disease. 4 The most widely used and cited list of causes amenable to health care is that of Nolte and McKee. Preventable burden involves disease burden that could be avoided through public health programmes or policies focused on wider determinants of health, such as behavioural and lifestyle influences, environmental factors, and socioeconomic status. 2, 3 For some causes, both personal health care and public health programmes and policies can reduce burden.
Within the GBD framework, we have two related terms: attributable and avoidable burden.
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Attributable burden refers to the difference in disease burden observed at present and burden that would have been observed in a population if past exposure was at the lowest level of risk.
Avoidable burden concerns the reduction in future disease burden if observed levels of risk factor exposure today were decreased to a counterfactual level.
For this study, we use the definition of amenable burden and focus on amenable mortality to provide a signal on approximate average levels of national personal health-care access and quality. Future analyses facilitated through the GBD study aim to provide more comprehensive assessments of health systems using amenable burden and preventable burden.
Garbage codes refer to causes certified by physicians on death certificates that cannot or should not be considered the actual underlying causes of death. Examples include risk factors like hypertension, non-fatal conditions like yellow nails, and causes that are on the final steps of a disease pathway (eg, certifying cardiopulmonary arrest as the cause when ischaemic heart disease is the true underlying cause of death). A vital strength of the GBD Study is its careful identification of garbage codes by cause, over time, and across locations, and subsequent redistribution to underlying causes based on the GBD cause list.
Risk-standardisation involves removing the joint effects of environmental and behavioural risk exposure on cause-specific mortality rates at the country or territory level for each year of analysis, and then adding back the global average of environmental and behavioural risk exposure for every geography-year. The goal of risk-standardisation is to eliminate geographic or temporal differences in cause-specific mortality due to variations in risk factors that are not immediately targeted by personal health care-and thus provide comparable measures of outcomes amenable to personal health-care access and quality over place and time.
Frontier analysis refers to the approach used for ascertaining the highest achieved values on the Healthcare Access and Quality Index (HAQ Index) on the basis of development status, as measured by the Socio-demographic Index (SDI). The HAQ Index frontier delineates the maximum HAQ Index reached by a location as it relates to SDI; if a country or territory falls well below the frontier value given its level SDI, this finding suggests that greater gains in personal health-care access and quality should be possible based on the country or territory's place on the development spectrum.
occur if health-care quality is heterogeneous within countries. [37] [38] [39] [40] Additionally, existing lists might exclude causes for which health care can avert death, such as the effects of trauma care on various injuries, 4, 41, 42 and the ages at which personal health care can reduce mortality, namely beyond the age of 75. 43, 44 The goal of this analysis is to use estimates of mortality amenable to personal health care from the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) to approximate access to and quality of personal health care in 195 countries and territories from 1990 to 2015. Quantifying access to and quality of personal health care has many policy uses, and no consistent measures of personal health-care access and quality currently list across the development spectrum; for instance, the World Bank coverage index only includes three interventions, 45 and the 2010-11 International Labour Organization's indicator of formal health coverage covered 93 countries, with substantial data missingness for subSaharan Africa. 46 The highly standardised cause of death estimates generated through GBD, 47 along with risk factor exposure, 48 can address several limitations associated with previous studies of amenable mortality. GBD provides comprehensive, comparable estimates of cause-specific death rates by geography, year, age, and sex through its extensive data correction processes to account for variations in cause of death certification. 47 The quantification of risk exposure and risk-attributable deaths due to 79 risk factors through GBD allows us to account for variations in risk exposure across geographies and time, 48 and thus helps to isolate variations in death rates due to personal health-care access and quality. We also examine the relationship between our measure of health-care access and quality, as defined by risk-standardised mortality rates amenable to health care, across development levels, as reflected by the Socio-demographic Index (SDI). Finally, we produce a frontier of maximum levels of personal health-care access and quality observed on the basis of SDI, which allows us to quantify the potential for further improvement in relation to development status.
Methods

Overview
We employed the most widely cited and used framework for assessing mortality amenable to personal health care. 4, 9, 11, 30, 31, 35 The Nolte and McKee cause list does not include all possible causes for which health care can improve survival; however, it does provide a set of conditions for which there is a reasonable consensus that personal health care has a major effect (table 1) . Starting with this list, our analysis followed four steps: mapping the Nolte and McKee cause list to GBD causes; riskstandardising mortality rates to remove variations in death rates not easily addressed through personal health care; computing a summary measure of personal health-care access and quality using principal component analysis (PCA); and assessing the highest recorded levels of healthcare access and quality across the development spectrum.
This study draws from GBD 2015 results; further detail on GBD 2015 data and methods are available 
Injuries
Unintentional injuries
Adverse effects of medical treatment 0-74
The age groups for which mortality is regarded as amenable to health care are listed. Causes are ordered on the basis of the GBD cause list and corresponding cause group hierarchies. GBD=Global Burden of Disease. elsewhere. [47] [48] [49] [50] For the present analysis, a vital strength of GBD is its careful evaluation and correction of cause of death certification problems and misclassification at the national level. In the GBD, we systematically identified causes of death that could not or should not be underlying causes of death (so-called garbage codes), and applied established statistical algorithms to correct for and redistribute these deaths. 51 Our study complies with the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER); 52 additional information on the data and modelling strategies used can be found in the appendix.
Mapping the Nolte and McKee amenable cause list to the GBD cause list
Drawing from Nolte and McKee's list of 33 causes amenable to personal health care, 4, 9, 11, 30, 31, 35 we mapped these conditions to the GBD cause list based on corresponding International Classification of Diseases (ICD) codes (appendix p 18). In GBD, thyroid diseases and benign prostatic hyperplasia are part of a larger residual category and thus were excluded. Diphtheria and tetanus are separate causes in GBD so we reported them individually. Because of its extensive processes used to consistently map and properly classify ICD causes over time, 47, 53 GBD supported the assessment of 32 causes on the Nolte and McKee cause list from 1990 to 2015.
Age-standardised risk-standardised death rates
Some variation in death rates for amenable causes are due to differences in behavioural and environmental risk exposure rather than differences in personal health-care access and quality. 48, 54, 55 Using the wide range of risk factors assessed by GBD, 48 we risk-standardised death rates to the global level of risk exposure. 48 We did not riskstandardise for variations in metabolic risk factors directly targeted by personal health care: systolic blood pressure, total cholesterol, and fasting plasma glucose. For example, stroke deaths due to high systolic blood pressure are amenable to primary care management of hypertension.
To risk-standardise death rates, we removed the joint effects of national behavioural and environmental risk levels calculated in GBD, and added back the global levels of risk exposure:
where m jascy is the death rate from cause j in age a, sex s, location c, and year y; mr jascy is the risk-standardised death rate; JPAF jascy is the joint population attributable fraction (PAF) for cause j, in age a, sex s, country c, and year y for all behavioural and environmental risks included in GBD; and JPAF jasgy is the joint PAF for cause j, in age a, sex s, and year y at the global level.
GBD provides joint PAF estimation for multiple risks combined, which takes into account the mediation of different risks through each other. Further detail on joint PAF computation is available in the appendix (pp [5] [6] [7] [8] .
We used the GBD world population standard to calculate age-standardised risk-standardised death rates from each cause regarded as amenable to health care. 47 We did not risk-standardise death rates from diarrhoeal diseases as mortality attributable to unsafe water and sanitation was not computed for high-SDI locations; such standardisation could lead to higher riskstandardised death rates in those countries compared with countries where mortality was attributed to unsafe water and sanitation. 48 With all causes for which no PAFs are estimated in GBD, such as neonatal disorders and testicular cancer, risk-standardised death rates equalled observed death rates.
The effects of risk-standardisation are highlighted by comparing the log of age-standardised mortality rates to To construct the Healthcare Access and Quality (HAQ) Index, we first rescaled the log age-standardised riskstandardised death rate by cause to a scale of 0 to 100 such that the highest observed value from 1990 to 2015 was 0 and the lowest was 100. To avoid the effects of fluctuating death rates in small populations on rescaling, we excluded populations less than 1 million population from setting minimum and maximum values. Any location with a cause-specific death rate below the minimum or above the maximum from 1990 to 2015 was set to 100 or 0, respectively. Because each included cause provided some signal on average levels of personal health-care access and quality, we explored four approaches to construct the HAQ Index: PCA, exploratory factor analysis, arithmetic mean, and geometric mean. Details on these four approaches are in the appendix (pp 7, 8, 21, 22) . All four measures were highly correlated, with Spearman's rank order correlations exceeding r s =0·98. We selected the PCAderived HAQ Index because it provided the strongest correlations with six other currently available crosscountry measures of access to care or health-system inputs (table 2). Three indicators came from the GBD Study 2015: health expenditure per capita, hospital beds per 1000, and the UHC tracer intervention index, a composite measure of 11 UHC tracer interventions (four childhood vaccinations; skilled birth attendance; coverage of at least one and four antenatal care visits; met need for family planning with modern contraception; tuberculosis case detection rates; insecticide-treated net coverage; and antiretroviral therapy coverage for populations living with HIV). 56 Three indicators came from WHO (physicians, nurses, and midwives per 1000), 57 the International Labour Organization, 46 and the World Bank (coverage index based on diphtheria-pertussis-tetanus vaccine coverage, coverage of at least four antenatal care visits, and proportion of children with diarrhoea receiving appropriate treatment). 45 All indicators had correlation coefficients greater than 0·60, and three exceeded 0·80 (health expenditure per capita, the UHC tracer index, and International Labour Organization formal health coverage).
The appendix (pp 21, 22) provides final rescaled PCA weights derived from the first five components that collectively accounted for more than 80% of the variance in cause-specific measures. Colon and breast cancer had negative PCA weights, which implied higher death rates were associated with better access and quality of care; because this cannot be true we set these weights to zero in the final PCA-derived HAQ Index. The appendix (p 15) compares each geography's HAQ Index in 2015 with the log of its age-standardised risk-standardised mortality rates.
Quantifying maximum levels of the HAQ Index across the development spectrum
To better understand maximum levels of personal healthcare access and quality potentially achievable across the development spectrum, we produced a frontier based on the relationship between the HAQ Index and SDI. We tested both stochastic frontier analysis models and data envelopment analysis; however, the relationship between SDI and the HAQ Index did not fit standard stochastic frontier analysis models, 58 and data envelopment analysis cannot account for measurement error and is sensitive to outliers. 59 To generate a frontier fit that closely follows the observed HAQ Index and allowed for measurement error, we used free disposal hull analysis on 1000 bootstrapped samples of the data. 58 Every bootstrap included a subset of locations produced by randomly sampling (with replacement) from all GBD geographies. The final HAQ Index value was drawn from the uncertainty distribution for each location-year, with outliers removed by excluding super-efficient units; additional methodological detail can be found in the appendix (pp [9] [10] [11] [12] . Last, we used a Loess regression to produce a smooth frontier for each five-year interval from 1990 to 2015. For every geography, we report the maximum possible HAQ Index value on the basis of SDI in 1990 and , while values for all years can be found in the appendix (pp [23] [24] [25] [26] [27] [28] .
Uncertainty analysis
GBD aims to propagate all sources of uncertainty through its estimation process, 47, 48 which results in uncertainty intervals (UIs) accompanying each point estimate of death by cause, geography, year, age group, and sex. We computed the HAQ Index for each geography-year based on 1000 draws from the posterior distribution for each included cause of death. We report 95% UIs based on the ordinal 25th and 975th draws for each quantity of interest.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Results
Distinct geographic patterns emerged for overall HAQ Index levels and gains from 1990 to 2015 (figure 1). Andorra and Iceland had the highest HAQ Index in 1990, whereas most of sub-Saharan Africa and south Asia and In addition to the HAQ Index, all causes presented in this figure are scaled 0 to 100, with 100 being the "best" value (ie, lowest observed age-standardised risk-standardised mortality rate by cause) and 0 being the "worst value" (ie, highest observed age-standardised risk-standardised mortality rate by cause) between 1990 and 2015. Comparing the overall HAQ Index with its component parts showed substantial heterogeneity in 2015, even within similar SDI quartiles (figure 2). Within the fourth SDI quartile, most geographies performed well on several vaccine-preventable diseases, including measles, diphtheria, tetanus, and whooping cough, yet some experienced lower values for communicable conditions such as lower respiratory infections. Geographies in the fourth SDI quartile generally performed worse for cancers, but many recorded values exceeding 90 for cervical and uterine cancers. Nearly all geographies in the fourth SDI quartile 
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Low SDI Low-middle SDI Middle SDI High-middle SDI High SDI surpassed 90 for maternal disorders, while geographies in the third and second SDI quartiles showed far more diverse results. A similar pattern emerged in causes for which routine surgeries can easily avert mortality (eg, appendicitis and hernias) among third and second SDI quartile geographies, with some countries performing fairly well for such causes (eg, China, Turkey, Sri Lanka) while others lagged behind (eg, Mexico, Indonesia, South Africa). Many geographies in the third and second SDI quartiles not only had fairly low values for NCDs such as diabetes, chronic kidney disease, and hypertensive heart disease, but also fared poorly on a subset of infectious diseases (ie, tuberculosis, lower respiratory infections, and diarrhoeal diseases) and neonatal disorders. In the first SDI quartile, neonatal and maternal disorders, tuberculosis, lower respiratory infections, and diarrhoeal diseases often led to the lowest scaled values, while most geographies experienced relatively better performances for a subset of cancers. Notably, several countries in the first SDI quartile recorded fairly high values for vaccinepreventable diseases. By contrast, nearly all of these countries and territories saw values lower than 50 for causes associated with routine surgeries and more complex case management (eg, epilepsy, diabetes, and chronic kidney disease). For nearly all countries and territories, the HAQ Index has markedly improved since 1990, with 167 recording statistically significant increases by 2015 ( figure 3) . Because of incomplete data systems, uncertainty bounds were relatively large for lower-SDI countries, whereas uncertainty for higher-SDI countries-places where data systems are more complete and of high quality-was much smaller. Five countries with the largest significant increases for the HAQ Index were South Korea (high SDI), Turkey and Peru (high-middle SDI), and China and the Maldives (middle SDI). Among low-middle-SDI and low-SDI countries, Laos and Ethiopia saw among the greatest improvements in the HAQ Index; however, these gains were less pronounced due to wide uncertainty bounds.
Based on a frontier analysis, we found that, as SDI increases, the highest observed HAQ Index values also 
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North Africa and Middle East (Continued from previous page) rose (figure 4). Further, maximum HAQ Index levels achieved generally improved since 1990 across levels of SDI. Table 3 details each geography's HAQ Index values for 5-year intervals from 1990 to 2015, as well as their frontier HAQ Index levels on the basis of a location's SDI. Measuring the distance between a geography's observed HAQ Index in 1990 and 2015 and its frontier for these years provides a benchmark for potential gains in health-care access and quality-a metric that also considers the geography's relative resources on the basis of SDI. Additionally, comparing how differences between a given place's observed HAQ Index and frontier change over time can show where personal health-care access and quality have improved in parallel with changes in development. Worldwide, the average HAQ Index values significantly increased, but the average global frontier improved in tandem; subsequently, gaps between the global HAQ Index and frontier changed minimally between 1990 and 2015. While most regions recorded narrowing gaps between average HAQ Index values and maximum levels achieved, a subset saw negligible progress or widening differences (eg, southern subSaharan Africa, south Asia, and the Middle East). In 2015, 52 countries and territories had HAQ Index estimates that included the frontier within their uncertainty bounds, indicating these geographies met the maximum levels of personal health-care access and quality attained by locations of similar SDI. Conversely, 62 geographies fell further behind the HAQ Index frontier associated with their level of SDI; this trend was especially pronounced in much of southern subSaharan Africa, Iraq, Pakistan, and Honduras ( figure 5 ). This result was in stark contrast with several countries in eastern and western sub-Saharan Africa (eg, Burundi, Comoros, Rwanda), Turkey, Peru, and South Korea, many of which more than halved the differences between their HAQ Index and frontiers given their SDI by 2015.
Discussion
Drawing from GBD 2015, we constructed a novel measure of personal health-care access and quality-the HAQ Index-by using highly standardised estimates of 32 different causes that are amenable to personal health care. Compared with previous efforts, the HAQ Index provides a clearer signal on personal health-care access and quality over time and place because GBD provides enhanced comparability of cause of death data, helps to account for variation due to behavioural and environmental risk factors, and includes 195 countries and territories over time. Our analysis showed large differences in personal health-care access and quality, spanning from a low of 23·1 in Ethiopia in 1990 to higher than 90 in Andorra, Iceland, Switzerland, Norway, and Sweden in 2015. The global HAQ Index improved from 40·7 in 1990 to 53·7 in 2015, and 167 of 195 countries and territories significantly increased their HAQ Index during this time. Although the HAQ Index and SDI were highly correlated, we noted substantial heterogeneity for geographies at similar SDI. If every location reached the highest observed HAQ Index experienced by level of SDI, our global measure of health-care access and quality could have reached 73·8 in 2015-a clear indicator of untapped potential for health-care improvement worldwide.
While most countries saw progress on the HAQ Index since 1990, the marked improvements recorded for countries including South Korea, Turkey, and China highlight that much more rapid advances are possible. A subset of countries narrowed the gap between observed personal health-care access and quality and what could be expected given their level of development-and then achieved gains beyond what might be anticipated on the basis of SDI. Peru, the Maldives, and Ethiopia are examples of such stand-out geographies for reaching higher-than-expected levels of personal health care and access since 1990. Case studies conducted by the World Bank highlight potential drivers of these countries' successes, 60 and additional research on how certain health-system attributes, including financing arrangements, provider ownership, and stewardship functions, are related to personal health-care access and quality is warranted. Separating out measures of access from quality of care received would be ideal, especially because programmatic and policy options to address barriers in access and quality can differ across and within countries. Nonetheless, such information measured in a consistent manner is rarely available. 34, 46, 57, 60 Several geographies had minimal gains in reducing the difference between their observed HAQ Index and the highest levels achieved at a similar SDI-a warning sign that heightened health-care access and quality is not an inevitable product of increased development. Further, a subset of countries in southern sub-Saharan Africa, south Asia, and the Middle East saw widening gaps between HAQ Index values in 2015 and the frontier reached by countries of comparable SDI. These findings could reflect several challenges faced by these countries, including subnational inequalities in both wealth and health-care options; and recent or rapid epidemiological transitions wherein the health-care sector and causespecific services offered trail behind the diseases afflicting populations. Along with examining the drivers of greater-than-expected gains, future studies should strive to understand why other countries are lagging behind-and how they can pursue advancing health-care access and quality for all individuals.
Improving personal health-care access and quality is an important priority in the SDG era, emphasising the potential utility of the HAQ Index for SDG monitoring. At present, the UHC target-SDG 3.8-focuses mainly on so-called tracer interventions in the areas of maternal and child health, reproductive health, and a subset of infectious diseases, 61 and thus fails to adequately capture the vital role of personal health care for NCDs and injuries. The HAQ Index provides a more comprehensive measure that reflects health-system capacity for effectively detecting risk for, managing, and preventing early death from a range of conditions. Combining the HAQ Index, coverage of health interventions, and prevalence of risk factors that are modifiable through public health initiatives could provide a more robust mechanism for tracking UHC progress across multiple dimensions of health-system action.
Health systems can provide differential access and quality across therapeutic areas and levels of care. The HAQ Index reflects the average experience as captured by included conditions, and does not currently distinguish between diseases more strongly related to primary or secondary care. Our PCA weights suggest some conditions are less highly correlated with other causes, including colon cancer, breast cancer, testicular cancer, non-melanoma skin cancer, or diphtheria. The comparatively low weights on these outcomes could reflect measurement error, residual challenges in risk standardisation, or health-system heterogeneity by level of care. Subnational work that identifies variation in personal health-care access and quality within a particular health-system structure, and that uses multi-method approaches to view the health system from the perspective of patients and frontline providers, 62, 63 may help elucidate whether some health-system components function distinctly from its average. For example, access to and quality of oncology care might be relatively distinct from other health-system dimensions and, where appropriate treatment is contingent on specialists or particular equipment, such as radiotherapy for cancer, even a temporary loss of these resources may substantially affect outcomes. 64 Conversely, access to high-quality primary care services, which enable early detection of conditions that are fatal if diagnosed at later stages, can be shaped by different factors, such as flexibility of clinic hours or types of insurance providers accepted.
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Mortality amenable to personal health care and mortality attributable to modifiable behavioural and environmental risk factors
For the present study, we based the HAQ Index on the list of causes established by Nolte and McKee, 4, 9, 11, 30, 31, 35 and did not systematically re-examine scientific literature to update causes for which personal health care can significantly improve outcomes. Conducting this kind of systematic review is crucial to identifying additional causes for inclusion in the HAQ Index. Numerous causes should be considered, and would likely result in adding antiretroviral therapy for HIV, artemisinin-based combination therapies for malaria, treatment of hepatitis C, and improvements in emergency and trauma care, among others. 41, 42, [66] [67] [68] [69] Expanding the amenable cause list should be determined by clear criteria that define when health care sufficiently reduces cause-specific mortality and thus provides a strong enough signal about access and quality. Such additions will probably improve the HAQ Index, though the nature of PCA estimation and its measurement of common variance across 32 causes may not substantially change future results. This analysis stemmed from existing scientific literature on mortality amenable to health care, but personal health care also can have profound effects on non-fatal health outcomes (eg, hip replacement for oesteoarthritis or surgery for cataracts). Future updates of the HAQ Index should consider incorporating measures of non-fatal conditions amenable to personal health care, which would then capture health-system capacity to deliver health gains through improved functional health status.
Understanding how much mortality or disease burden is avertable based on providing access to high-quality personal health care and modifying behavioural and environmental risks through public health initiatives is of high policy interest. GBD currently assesses mortality and burden attributable to a large set of risk factors, which supplies useful insights on the potential of risk modification to improve health. Quantification of the full potential of personal health care to reduce burden by cause would provide an important additional piece of policy-relevant information. Controlling for other factors through statistical modelling, such as income and educational attainment, we could examine how much cause-specific variation relates to the HAQ Index. Such work would help to pinpoint opportunities for national and subnational progress through health-system improvements, which would likely include public health programmes and policies as well as the organisation and delivery of personal health services across levels of care.
Moving to performance measurement
In estimating the HAQ Index frontier by SDI, 58 we quantified the gap between observed personal healthcare access and quality and levels potentially achievable at a given level of SDI. With these analyses, we lay the foundation for a refined assessment of health-system performance. The World Health Report 2000, which sought to evaluate health-system performance by country, 70 estimated the contribution of health systems for improving healthy life expectancy while statistically controlling for other factors. As suggested by Nolte and McKee, 9, 71 using a measure more directly related to health-system actions, such as mortality amenable to personal health care, could reduce the need to control for other factors in health-system performance assessment. The World Health Report 2000 framework used five broad dimensions-average levels of health, inequalities in health, average levels of health-system performance, inequalities in responsiveness, and fair financing-and then compared overall health system attainment based on a frontier for health expenditure per capita. 71 Our current analysis only focused on the contribution of personal health care to mortality and the potential for improvement in this domain relative to development. In the future, GBD could support examining subnational health inequalities and expanding into health finance quantification of financial risk protection. A stronger empirical basis for assessing these three domains of health-system performance would also facilitate testing a range of efficiency and performance models.
Our frontier analysis showed that the highest observed HAQ Index levels, as achieved by geographies with an SDI of 0·8 or higher, steadily shifted higher over time. This expansion of health-care access and quality may reflect a rising share of GDP allocated to health among high-SDI countries. However, the frontier estimate for GDP per capita spent on health points to a similar shift upward at high expenditure. One explanation of this trend is new medical technologies and programmes, which could be driving an overall upward shift in health-care access and quality achievable in well financed systems. Another potential explanation is innovation in health-care organisation, such as the creation of centralised stroke care units in major cities. 72 A more detailed examination of these changes may further elucidate how investing in medical innovations can affect health-system performance.
In particular, this might shed light on the association between investment in health-care resources and outcomes, a relationship that is unlikely to be linear. For instance, audits have identified three main factors underlying maternal deaths: sub standard care, delays in care, and problems with blood transfusions. 73 Addressing the latter requires a different type of intervention, namely investments in infrastructure, than the former two factors. Such knowledge is of particular importance in the SDG era, as some studies point to advances in medical technology and innovation as the primary pathway for elevating health alongside increasing development.
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HAQ Index compared to other measures of access and quality of care
Detailed results on HAQ Index components seem consistent with previous, albeit limited, studies on healthcare performance. Within Europe, Nordic countries performed especially well, corresponding with past work on a composite measure of public health policies. 75 Country performance on diabetes aligned with earlier work on diabetes mortality and incidence, 25 wherein country-level differences were largely explained by known health-system changes, such as substantial improvements in several Baltic states during the late 1990s. In Latin America, Costa Rica's relatively high HAQ Index (72·9), as compared with nearby countries (eg, Nicaragua [64·3], Guatemala [55·7]), is consistent with its designation as an original "good health at low cost" country. 76 In view of the paucity of standard health-care access and quality measures, assessing HAQ Index validity compared to other indicators was challenging. In this analysis, we identified three measures of health-system resources and three measures of intervention coverage that included at least 70 countries. These correlations, which all exceeded 0·60, offer some evidence of convergent validity but do not provide criterion validity. 77, 78 Nonetheless, these results are encouraging and stand in contrast to previous studies done in limited settings. [37] [38] [39] [40] In comparison with past work, 9, 11, 31 the moderately high correlation with other health-care indicators might be due to our efforts to riskstandardise mortality amenable to health care; PCA weighting of different amenable conditions; and the inclusion of a substantively larger, more diverse set of health systems across the development spectrum. Additional validation analyses are needed to compare HAQ Index performance with other measures of healthcare access and quality; such validation exercises might be more feasible at the subnational level with greater data density, such as states in the USA.
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Limitations
This analysis has a number of limitations beyond those already described. First, many limitations experienced in GBD cause of death estimation are applicable to this study. 47 Second, our risk-standardisation procedure might not represent all possible risk-outcome pairs as they pertain to included causes of amenable mortality (eg, determinants of testicular cancer or neonatal disorders). 48 With its annual updates, GBD aims to improve upon its comparative risk assessment, and thus HAQ Index assessment is likely to be improved alongside advances in risk quantification. Third, two causes received negative weights in the PCA analysis and were subsequently excluded. One potential explanation for this is that joint PAFs for these causes may underestimate riskattributable mortality in high-SDI countries (eg, the effects of diet, obesity, and physical inactivity for breast cancer). However, given the high Spearman's rank order correlation between the average of all 32 causes and the HAQ Index, excluding these causes from the PCA likely had minimal effect on our results. Fourth, we used PCA to construct the HAQ Index based on age-standardised risk-standardised death rates from the 32 causes. Alternative methods for index construction led to highly correlated results, but exact rankings somewhat varied. We subsequently view exact rank orders as less useful than comparing a given geography's HAQ Index values over time, to countries of similar SDI, and relative to the HAQ Index frontier. Fifth, while the HAQ Index offers a more robust indicator of overall health-care access and quality than currently available measures, it does not directly capture effects of personal health care on causes without substantial mortality (eg, depression, hip oesteoarthritis, and cataracts). The effects of health care on both fatal and nonfatal conditions may be highly correlated, but incorporating how access and quality of care explicitly affect non-fatal outcomes would improve measurement. Sixth, GBD corrections for cause of death misclassifications (so-called garbage codes) varies substantially by geography and thus can affect results. Even among high-SDI countries, GBD showed substantial variation for the proportion of amenable deaths assigned to garbage codes, ranging from 7·9% in Finland to 39·8% in Portugal (appendix p 19). Seventh, for countries with complete or nearly complete vital registration (VR) data and few deaths misclassified based on ICD codes, the HAQ Index may be more robust and less prone to high levels of uncertainty than for countries with lower-quality or non-existent VR data. Mortality estimates that heavily draw from verbal autopsy data or other modelling approaches have larger UIs. Our results for most of sub-Saharan Africa, for example, include wide UIs and thus few countries recorded HAQ Index values that statistically differed from the regional mean. Eighth, we rescale the log age-standardised riskstandardised death rate for each cause from 0 to 100 using the observed range across countries from 1990 to 2015, but achieving 100 does not mean that additional improvement is not possible. Subsequently, the HAQ Index range reported here is relative to national achievements to date, and these thresholds may rise if or when improved personal health-care access and quality occurs for given causes. Ninth, the HAQ Index does not currently capture subnational inequalities in personal health-care access and quality, which might emerge on the basis of geographic location or socioeconomic status, among other factors. Future efforts to quantify these measures with greater geospatial resolution should be prioritised.
Conclusions
Our analysis demonstrates that a policy-relevant summary measure of personal health-care access and quality can be derived from GBD. This novel measure supports the firstever comparable assessment of personal health-care access and quality across 195 countries and territories, over time, and along the development spectrum. The HAQ Index considerably advances previous efforts to approximate personal health-care access and quality by systematically adjusting for cause of death certification biases and misclassification, risk-standardising death rates across geographies, and applying PCA to identify common dimensions of health-care access and quality associated with multiple conditions. Globally, most countries and territories recorded gains in personal health-care access and quality from 1990 to 2015, yet many still experienced levels that fell well below what has been achieved by geographies at a similar development status. Amid calls to improve monitoring of UHC and overall health-system performance, the HAQ Index provides a strong basis for benchmarking progress toward greater access and higher-quality personal health care alongside country-level gains in resources to achieve these aims.
